Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0649

+0.6%

Nov 13 3:42 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

pincus

From: Howard Williams	9/4/2013 8:42:52 AM
	1 Recommendation of 13111

Here and there, thanks to the PVCT blog ..... ******************************************** sciencedirect.com "This study suggests that RB preferentially suppress gastric cancer cell growth through the induction of apoptosis, mitigating the further examination of RB in animal models of gastric cancer. In this study, for the first time, we also showed anti-inflammatory effect of RB." And ...... articles.mums.ac.ir "Thus RB exerts proapoptotic effects in a MCF-4 cells and could be considered as a potential chemotherapeutic agent in breast cancer."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next